OC Ophthotech Corp. Stock: price and management transactions · United States · SEC (Form 4)Follow the Ophthotech Corp. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 2 February 2016 (Cession). Among the most active insiders: GUYER DAVID R. Every trade is accessible without an account.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 February 2016
All Executives43 Thresholds0 Prospectus0 Other0
Declarations 43 total
▼ President · Executives · 29 Jan 2016
11,418 shares Common Stock SEC:0001104659-16-093320:0
▼ President · Executives · 29 Jan 2016
8,482 shares Common Stock SEC:0001104659-16-093320:1
▼ President · Executives · 29 Jan 2016
100 shares Common Stock SEC:0001104659-16-093320:2
◇ Chief Executive Officer · Executives · 28 Jan 2016
18,598 shares Common Stock SEC:0001104659-16-092984:0
▼ Chief Executive Officer · Executives · 28 Jan 2016
14,198 shares Common Stock SEC:0001104659-16-092984:1
▼ Chief Executive Officer · Executives · 28 Jan 2016
3,200 shares Common Stock SEC:0001104659-16-092984:2
▼ Chief Executive Officer · Executives · 28 Jan 2016
600 shares Common Stock SEC:0001104659-16-092984:3
▼ Chief Executive Officer · Executives · 28 Jan 2016
600 shares Common Stock SEC:0001104659-16-092984:4
▼ Director · Executives · 11 Jan 2016
999 shares Common Stock SEC:0001104659-16-089676:0
▼ Director · Executives · 11 Jan 2016
1,001 shares Common Stock SEC:0001104659-16-089676:1
▼ Director · Executives · 11 Jan 2016
501 shares Common Stock SEC:0001104659-16-089676:2
▼ Director · Executives · 11 Jan 2016
499 shares Common Stock SEC:0001104659-16-089676:3
◇ SVP,General Counsel,Secretary · Executives · 4 Jan 2016
1,000 shares Common Stock SEC:0001104659-16-088437:0
▼ SVP,General Counsel,Secretary · Executives · 4 Jan 2016
1,000 shares Common Stock SEC:0001104659-16-088437:1
▼ Chief Executive Officer · Executives · 4 Jan 2016
108 shares Common Stock SEC:0001104659-16-088114:5
◇ EVP, CFO, & CBO, Treasurer · Executives · 2 Jan 2016
425 shares Common Stock SEC:0001104659-16-088108:0
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
34 shares Common Stock SEC:0001104659-16-088108:1
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
24 shares Common Stock SEC:0001104659-16-088108:2
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
45 shares Common Stock SEC:0001104659-16-088108:3
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
23 shares Common Stock SEC:0001104659-16-088108:4
▼ EVP, CFO, & CBO, Treasurer · Executives · 4 Jan 2016
4 shares Common Stock SEC:0001104659-16-088108:5
◇ Chief Executive Officer · Executives · 2 Jan 2016
5,750 shares Common Stock SEC:0001104659-16-088114:0
▼ Chief Executive Officer · Executives · 4 Jan 2016
862 shares Common Stock SEC:0001104659-16-088114:1
▼ Chief Executive Officer · Executives · 4 Jan 2016
600 shares Common Stock SEC:0001104659-16-088114:2
▼ Chief Executive Officer · Executives · 4 Jan 2016
1,121 shares Common Stock SEC:0001104659-16-088114:3
25 of 43 declarations
Load more (18 remaining) About Ophthotech Corp. Ophthotech Corp. is a biopharmaceutical company focused on developing treatments for eye diseases. It is listed on the NASDAQ under the ticker OPHT.